Aging, components of metabolic syndrome and serum C-reactive protein showed significant relationship with carotid atherosclerosis

References

• Zambon A, Pauletto P, Crepaldi G. Review article: The metabolic syndrome–a chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther. 2005;22 Suppl 2:20–23.
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007;30:8–13.
   PubMed Web of Science ®Google Scholar
• Mazza AD, Morley JE. Metabolic syndrome and the older male population. Aging Male. 2007;10:3–8.
   PubMed Web of Science ®Google Scholar
• Goncharov NP, Katsya GV, Chagina NA, Gooren LJ. Three definitions of metabolic syndrome applied to a sample of young obese men and their relation with plasma testosterone. Aging Male. 2008;11:118–122.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Unwin N, Bhopal R, Hayes L, White M, Patel S, Ragoobirsingh D, Alberti G. A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults. Ethn Dis. 2007;17:522–528.
   PubMed Web of Science ®Google Scholar
• Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32:1092–1097.
   PubMed Web of Science ®Google Scholar
• Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: Prospective data from the Bruneck study. Diabetes Care. 2003;26:1251–1257.
   PubMed Web of Science ®Google Scholar
• Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchiger B. Prediction of cardiovascular morbidity and mortality: Comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke. 2006;37:800–805.
   PubMed Web of Science ®Google Scholar
• Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Løchen ML, Njølstad I, Arnesen E. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: A 6-year follow-up study of 6226 persons: The Tromsø Study. Stroke. 2007;38:2873–2880.
   PubMed Web of Science ®Google Scholar
• Uthoff H, Staub D, Meyerhans A, Hochuli M, Bundi B, Schmid HP, Frauchiger B. Intima-media thickness and carotid resistive index: Progression over 6 years and predictive value for cardiovascular events. Ultraschall Med. 2008;29:604–610.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37:87–92.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation. 2007;115:459–467.
   PubMed Web of Science ®Google Scholar
• Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II2–I10.
   PubMed Web of Science ®Google Scholar
• Koenig W. Predicting risk and treatment benefit in atherosclerosis: The role of C-reactive protein. Int J Cardiol. 2005;98:199–206.
   PubMedGoogle Scholar
• Kampus P, Kals J, Ristimäe T, Muda P, Ulst K, Zilmer K, Salonen RM, Tuomainen TP, Teesalu R, Zilmer M. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein. J Hypertens. 2007;25:819–825.
   PubMed Web of Science ®Google Scholar
• Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, D’Agostino RB Sr, Lipinska I, Keaney JF Jr, Benjamin EJ, O’Donnell CJ. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol. 2007;99:1598–1602.
   PubMed Web of Science ®Google Scholar
• Sander K, Horn CS, Briesenick C, Sander D; INVADE Study Group. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: The INVADE Study. Stroke. 2007;38:2881–2886.
   PubMed Web of Science ®Google Scholar
• Baldassarre D, De Jong A, Amato M, Werba JP, Castelnuovo S, Frigerio B, Veglia F, Tremoli E, Sirtori CR. Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med. 2008;40:21–44.
   PubMed Web of Science ®Google Scholar
• Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon H, Hanaire-Broutin H, Ferrières J. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis. 2006;186:345–353.
   PubMedGoogle Scholar
• Koskinen J, Kähönen M, Viikari JS, Taittonen L, Laitinen T, Rönnemaa T, Lehtimäki T, Hutri-Kähönen N, Pietikäinen M, Jokinen E, Helenius H, Mattsson N, Raitakari OT, Juonala M. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: The cardiovascular risk in young Finns study. Circulation. 2009;120:229–236.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391–397.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial nfarction: The Rotterdam Study. Circulation. 1997;96:1432–1437.
   PubMed Web of Science ®Google Scholar
• del Sol AI, Moons KG, Hollander M, Hofman A, Koudstaal PJ, Grobbee DE, Breteler MM, Witteman JC, Bots ML. Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke. 2001;32:1532–1538.
   PubMed Web of Science ®Google Scholar
• Willeit J, Kiechl S, Oberhollenzer F, Rungger G, Egger G, Bonora E, Mitterer M, Muggeo M. Distinct risk profiles of early and advanced atherosclerosis: Prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol. 2000;20:529–537.
   PubMedGoogle Scholar
• Spence JD. Technology Insight: Ultrasound measurement of carotid plaque–patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol. 2006;2:611–619.
   PubMedGoogle Scholar
• Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep. 2009;11:21–27.
   PubMedGoogle Scholar
• Pollex RL, Al-Shali KZ, House AA, Spence JD, Fenster A, Mamakeesick M, Zinman B, Harris SB, Hanley AJ, Hegele RA. Relationship of the metabolic syndrome to carotid ultrasound traits. Cardiovasc Ultrasound. 2006;4:28.
   PubMedGoogle Scholar
• Ishizaka N, Ishizaka Y, Hashimoto H, Toda E, Nagai R, Yamakado M. Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure. Hypertension. 2006;48:411–417.
   PubMed Web of Science ®Google Scholar
• Chen PC, Chien KL, Hsu HC, Su TC, Chang CW, Sung FC, Lee YT. C-reactive protein and the metabolic syndrome correlate differently with carotid atherosclerosis between men and women in a Taiwanese community. Metab Clin Exp. 2008;57:1023–1028.
   PubMed Web of Science ®Google Scholar
• Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI; Postmenopausal Estrogen/Progestin Intervention Trial. Association of endogenous sex hormones and insulin resistance among postmenopausal women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab. 2003;88:1646–1652.
   PubMed Web of Science ®Google Scholar
• Jiang CQ, Xu L, Lam TH, Lin JM, Cheng KK, Thomas GN. Smoking cessation and carotid atherosclerosis: The Guangzhou Biobank Cohort Study–CVD. J Epidemiol Community Health. 2010;64:1004–1009.
   PubMedGoogle Scholar
• Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review. Atherosclerosis. 2008;196:489–496.
   PubMed Web of Science ®Google Scholar